MPM Focus Area

Personalized therapeutics for
genetically defined cancer

Watch Now
Chris Bardon, MD Oncology Impact Fund, Discuss Advances in Cancer Therapies
Bloomberg Capital Markets, June 2016

Related Investment: Epizyme

Companies

MPM Investment Strategy

MPM Capital works with leading scientists to create companies that seek to address unmet needs and change the face of medicine across all therapeutic areas. MPM is currently investing out of BV2014, its most recent venture fund. In 2015 MPM partnered with UBS to create the UBS Oncology Impact Fund (OIF), an innovative impact investing fund focused exclusively on oncology that will invest in both private and public equities. OIF will support both basic cancer research as well as access to cancer care in developing countries.

Fund

Investments

Exit Type

Focus Area

MPM Team

MPM's Team is comprised of innovators, entrepreneurs, executives & investors

Role

Location

Contact Us

info@mpmcapital.com

Cambridge, MA

450 Kendall Street
Cambridge, MA 02142


Phone | 617-425-9200

see full map / get directions

San Francisco, CA

601 Gateway Boulevard
Suite 350
South San Francisco, CA 94080

Phone | 650-553-3300

see full map / get directions
Terms Of Use & Disclosures
  1. 2016
  2. 2015
  3. 2014